NCT07825519Active, not recruiting
Effectiveness of Enhanced Web-Based Health Education on Self-Care Practices and Quality of Life Among Patients With Hepatocellular Carcinoma Undergoing TACE
Effectiveness of Enhanced Web-Based Health Education on Self-Care Practices and Quality of Life Among Patients With Hepatocellular Carcinoma
Source: ClinicalTrials.gov · Last updated 17 Sept 2026
Brief summary (registry, in English)
This randomized controlled trial aims to evaluate the effectiveness of enhanced web-based health education on self-care practices and quality of life among patients with hepatocellular carcinoma. A total of 252 participants undergoing transarterial chemoembolization (TACE) will be randomly assigned to an intervention group or a control group. The intervention group will receive routine health education combined with enhanced web-based health education, while the control group will receive routine health education and printed educational materials. Knowledge, self-care practices, and quality of life will be assessed at baseline, 1 month, and 3 months after TACE. The study will determine whether enhanced web-based health education can improve self-care practices and quality of life in patients with hepatocellular carcinoma undergoing TACE.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 252 (actual)
- First submitted
- 13 Sept 2026
- Start date
- 13 Sept 2024
- Primary completion date
- 1 Oct 2026
- Lead sponsor
- University Medical Center Ho Chi Minh City (UMC)
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT07825519
What you commit to
- Study type: Interventional
- Participants enrolled: 252
- From 13 Sept 2024 to the primary completion date, 1 Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- • Patients with HCC scheduled to undergo TACE who have diagnosed cognitive impairment due to neurological disorders.
- Patients who are unable to understand spoken Vietnamese.
- Patients with language or hearing impairments that interfere with communication and participation in the study.
Who the study is looking for
- • Patients aged 18 years or older who are diagnosed with hepatocellular carcinoma (HCC) and are scheduled to undergo Transarterial Chemoembolization (TACE) for the first time at the Department of Hepatobiliary and Pancreatic Surgery, University Medical Center Ho Chi Minh City.
- Patients who agree to participate in the study and provide informed consent.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Medical Center Coordinator of this site? Confirm its status | Ho Chi Minh City | Vietnam | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.